Sophie Guillemard
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [18F]FDG PET/CT, 20 Years After Primary Diagnosis: A Case Report.
Journal: Clinical case reports
Published: March 20, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.
Journal: The oncologist
Published: December 10, 2024
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 29, 2024
LYMPHOSCORE (Lymphoscintigraphy Scoring Reliability) Reliability of a New Qualitative and Semiquantitative Lymphoscintigraphy Scoring System for Primary Lymphedema.
Journal: Clinical nuclear medicine
Published: June 25, 2024
Effectiveness of dupilumab on chronic lymphedema associated hand dermatitis.
Journal: Contact dermatitis
Published: April 21, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Journal: The Lancet. Oncology
Published: March 14, 2024
Ureteropelvic junction obstruction with primary lymphoedema associated with CELSR1 variants.
Journal: Journal of medical genetics
Published: January 19, 2023
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?
Journal: Annals of translational medicine
Published: September 19, 2022
Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?
Journal: Diagnostics (Basel, Switzerland)
Published: March 17, 2022
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: March 14, 2018
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 08, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026